Wemass Medical Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Wemass Medical General Information

Description

Manufacturer of implantable medical devices designed to advance minimally invasive drug delivery and clinical access pathways. The company offers implantable infusion ports for venous, arterial, analgesic, peritoneal, and dialysis applications, as well as intelligent drug delivery systems, enabling hospitals and physicians to enhance treatment safety, patient comfort, and therapeutic efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th and 7th floors, Building 10, Phase VI, Accelerator
  • Number 71 Xinghui Road, Jiangbei New District
  • Nanjing, Jiangsu 210044
  • China
+86 133
Primary Industry
Drug Delivery
Vertical(s)
Corporate Office
  • 6th and 7th floors, Building 10, Phase VI, Accelerator
  • Number 71 Xinghui Road, Jiangbei New District
  • Nanjing, Jiangsu 210044
  • China
+86 133

Wemass Medical Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wemass Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 10-Feb-2026 Completed Generating Revenue
2. Early Stage VC 20-Mar-2025 Completed Generating Revenue
1. Seed Round 30-Jun-2023 $2.8M $2.8M Completed Startup
To view Wemass Medical’s complete valuation and funding history, request access »

Wemass Medical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nanjing Southeast Investment Fund Management Growth/Expansion Minority
Shenzhen Xinhua Chuang Asset Management Growth/Expansion Minority
Huapeng Nuoyu Private Equity Fund Management Growth/Expansion Minority
Nanjing Jiangbei New Area Innovation Investment Fund Management PE/Buyout Minority
Suzhou Oriza Holdings Corporation Asset Manager Minority
You’re viewing 5 of 6 investors. Get the full list »

Wemass Medical FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process